Get started
PFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05PFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05PFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05

PFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

PFEC chart


Full chart

Key facts today


On July 15, 2025, Pfizer reported positive results from the JAVELIN Bladder 100 Trial, showing avelumab maintenance therapy improved survival compared to best supportive care in 496 patients.
TD Cowen has raised its price target on Pfizer (PFE) to $30 from $28, while keeping a 'Hold' rating on the stock.
Pfizer's ViiV Healthcare expanded its licensing deal with the Medicines Patent Pool to include cabotegravir patents, a vital part of long-acting HIV treatments, per WHO's updated guidelines.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪145.83 B‬ USD
Dividend yield (indicated)
6.65%
Price to earnings Ratio (TTM)
24.00
Basic EPS (TTM)
0.32 USD
Net income (FY)
‪7.12 B‬ USD
Revenue (FY)
‪56.51 B‬ USD
Shares float
—
Beta (1Y)
0.09

About Pfizer


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Albert Bourla
Website
pfizer.com
Headquarters
New York
Founded
1849
ISIN
ARDEUT111424
FIGI
BBG000HG7NC4
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Check out other big names from the same industry as PFEC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PFEC news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

PFEC highest yielding bonds


XS173899459
PFIZER INC. 17/43
Yield to maturity
7.25%
Maturity date
Jun 15, 2043
US717081FA6
PFIZER 20/50
Yield to maturity
7.13%
Maturity date
May 28, 2050
US717081EV1
PFIZER 19/49
Yield to maturity
6.52%
Maturity date
Mar 15, 2049
US717081EZ2
PFIZER INC 20/40
Yield to maturity
6.52%
Maturity date
May 28, 2040
US717081ED1
PFIZER 16/46
Yield to maturity
6.40%
Maturity date
Dec 15, 2046
US717081EK5
PFIZER 18/48
Yield to maturity
6.29%
Maturity date
Sep 15, 2048
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063
Yield to maturity
6.19%
Maturity date
May 19, 2063
US717081DE0
PFIZER INC. 13/43
Yield to maturity
6.07%
Maturity date
Jun 15, 2043
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053
Yield to maturity
6.06%
Maturity date
May 19, 2053
US717081DK6
PFIZER INC. 14/44
Yield to maturity
6.04%
Maturity date
May 15, 2044
P
PFE5588591
Pfizer Investment Enterprises Pte. Ltd. 5.11% 19-MAY-2043
Yield to maturity
5.86%
Maturity date
May 19, 2043

See all PFEC bonds 

Sparks


Curated watchlists where PFEC is featured.

See all sparks